CN Patent

CN119977993A — 噻吩并嘧啶二酮acc抑制剂的固体形式及其制备方法

Assigned to Gilead Apollo LLC · Expires 2025-05-13 · 1y expired

What this patent protects

本发明提供了用作乙酰基CoA羧化酶(ACC)的抑制剂的固体形式的化合物、其组合物、其制备方法和使用它们治疗ACC‑介导的疾病的方法。

USPTO Abstract

本发明提供了用作乙酰基CoA羧化酶(ACC)的抑制剂的固体形式的化合物、其组合物、其制备方法和使用它们治疗ACC‑介导的疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN119977993A
Jurisdiction
CN
Classification
—
Expires
2025-05-13
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Apollo LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.